Cancer Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2022-03-28 ms3000001537670222

这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。

33 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2022-02-17 ms9000001452564770

投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？

57 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2022-03-22 木木木木木木林123

请问版面费真的要3700美元吗

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2021-09-10 繁芜

我来报喜啦，努力没有白费！
7.26投稿
8.31小修
9.7返修
9.10接收
我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！

106 27

展开27条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2022-03-20 12133f96m16(暂无昵称)

这个杂志要原始数据不

29 0

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2022-03-13 纳苨

偏重的研究方向：综述;肝癌
经验分享：有投这个杂志的综述的么？好接受吗请问

23 0

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2020-05-20 148a8648m07暂无昵称

亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表::
今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表:
今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。

137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。

89 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2021-09-25 灌水达人

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肾癌铁死亡
经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。

41 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2022-02-21 淡墨轻烟

做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。

46 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1206749, encodeId=b1891206e4934, content=这杂志真的慢啊。。pending editor assignment 1个多月了，慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b855607971, createdName=ms3000001537670222, createdTime=Mon Mar 28 23:32:47 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194268, encodeId=285a119426891, content=投稿20多天了还是pending editor assignment 请问在哪里可以联系编辑催促进度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=20035621359, createdName=ms9000001452564770, createdTime=Thu Feb 17 00:25:09 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204965, encodeId=039b1204965cc, content=请问版面费真的要3700美元吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b0571642823, createdName=木木木木木木林123, createdTime=Tue Mar 22 16:14:29 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016303, encodeId=8da210163030c, content=我来报喜啦，努力没有白费！ 7.26投稿 8.31小修 9.7返修 9.10接收 我总觉得一切都像做梦一样，感谢给予我帮助的每一个人！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=27, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210912/48ddb68c7423473b924011dbd600ebd4/960c93aa735a40708b9a8471d0ab5b94.jpg, createdBy=17c95497501, createdName=繁芜, createdTime=Fri Sep 10 12:51:33 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204328, encodeId=faa61204328a4, content=这个杂志要原始数据不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Mar 20 12:47:17 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202229, encodeId=3a8c1202229ea, content=偏重的研究方向：综述;肝癌 经验分享：有投这个杂志的综述的么？好接受吗请问, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=35ac5549789, createdName=纳苨, createdTime=Sun Mar 13 15:59:34 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591343, encodeId=c499591343b6, content=亲，想投生信的，好中么137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。137****5628暂无昵称 2020-05-04 00:00:00 发表: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, beContent=137****5628暂无昵称 2020-05-04 发表:: 今天给了意见让小修，加总结和补实验（第一次大修其实就说到了，但是碍于疫情实在是不知道什么时候能做实验就没补直接修回去了），该做的还是得做的，只不过我现在还是没法回学校做实验，难过，我就不信再过一个月还不能在实验室呆着TAT。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1685320261, createdName=148a8648m07暂无昵称, createdTime=Wed May 20 00:00:00 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054740, encodeId=72df1054e40a6, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肾癌铁死亡 经验分享：7月份投了一篇铁死亡相关的文章，按照工作量其实可以投5+的杂志，为了省事投了cancer medicine，50天左右收到一审结果，得到评审肯定，只是让改了下图片大小，遂接收。作为科研民工都想让自己的稿子利益最大化，但有时候也不容易，除了以小博大，走稳妥的投稿策略也能让返修时少受折磨。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08bb5128054, createdName=灌水达人, createdTime=Sat Sep 25 17:58:47 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195860, encodeId=2d5211958600d, content=做的生信，去年10月投稿，12月大修，1月小修，小修的时候发信息说改改图片格式和数据库参考文献就差不多了，结果2月拒稿，拒稿理由编辑之前都没提过，我哭都没地哭，简直浪费时间。唉，累了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/B91E9B1EA0B0FABC63880D6C5C832592/100, createdBy=a2142411170, createdName=淡墨轻烟, createdTime=Mon Feb 21 21:47:26 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195705, encodeId=818d1195e0576, content= 亲，请问下pending recommendation是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=080c5488805, createdName=ms9000000156680607, createdTime=Mon Feb 21 15:23:20 CST 2022, time=2022-02-21, status=1, ipAttribution=)]

2022-02-21 ms9000000156680607

亲，请问下pending recommendation是什么意思？

28 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务